I have perviously expressed my opinion that serious mismanagement and strong competition was impacting us, but the margin compression highlighted by these results is much worse than I expected.
Profit was down a whopping 59.25% compared to pcp!
Patients are also up in arms about recent changes to Canview which has severely restricted the marketplace functionality they can access.
My only hope is that our new independent chair, Mr. Iervasi, is not beholden to the CEO and will recognise the need for renewal at the top.
Ann: Half Yearly Report and Accounts, page-4
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.015(14.3%) |
Mkt cap ! $69.10M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.0¢ | $87.66K | 796.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 88095 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 23159 | 2 |
View Market Depth
| Last trade - 15.59pm 18/10/2024 (20 minute delay) ? |
| VIT (ASX) Chart |